Beta-blockers in hypertension: truths and half-truths.
作者信息
Ram C Venkata S
出版信息
J Clin Hypertens (Greenwich). 2008 Jul;10(7):516-9. doi: 10.1111/j.1751-7176.2008.08356.x.
Abstract
摘要
相似文献
1
Beta-blockers in hypertension: truths and half-truths.β受体阻滞剂治疗高血压：真相与半真半假之事。
J Clin Hypertens (Greenwich). 2008 Jul;10(7):516-9. doi: 10.1111/j.1751-7176.2008.08356.x.
2
[Current and future strategy for antihypertensive medication].[当前及未来的抗高血压药物治疗策略]
Nihon Yakurigaku Zasshi. 2006 May;127(5):393-8. doi: 10.1254/fpj.127.393.
3
[Management of hypertension in upheaval?].高血压管理陷入动荡？
Dtsch Med Wochenschr. 2005 Nov 18;130(46):2627. doi: 10.1055/s-2005-922044.
4
Selecting antihypertensive medication in patients with essential hypertension in Malaysia.马来西亚原发性高血压患者的降压药物选择
Med J Malaysia. 2009 Mar;64(1):3-11.
5
Treatment of hypertension.高血压的治疗。
J Pract Nurs. 2006 Spring;56(1):11-5; quiz 18-9.
6
[Antihypertensive drug therapy--combination of AT1-receptor blocker and betablocker].[抗高血压药物治疗——血管紧张素Ⅱ1型受体阻滞剂与β受体阻滞剂联合使用]
Dtsch Med Wochenschr. 2010 May;135(3):98. doi: 10.1055/s-0029-1244825. Epub 2010 Jan 14.
7
[Blood pressure control in Europe is worse than in the USA].欧洲的血压控制情况比美国更差。
G Ital Nefrol. 2007 Jul-Aug;24(4):284.
8
[Pharmacological hypertension therapy].[高血压的药物治疗]
Ugeskr Laeger. 2009 Jun 8;171(24):2022-5.
9
Summaries for patients. Effect of antihypertensive drugs on risk for atrial fibrillation.患者摘要。抗高血压药物对心房颤动风险的影响。
Ann Intern Med. 2010 Jan 19;152(2):I-16. doi: 10.7326/0003-4819-152-2-201001190-00001.
10
[Treatment of hypertension with angiotensin blockers].[使用血管紧张素阻滞剂治疗高血压]
Fortschr Med Suppl. 1997;182:1-12.
本文引用的文献
1
A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus.一项对94492例接受β受体阻滞剂治疗的高血压患者进行的荟萃分析，以确定新发糖尿病的风险。
Am J Cardiol. 2007 Oct 15;100(8):1254-62. doi: 10.1016/j.amjcard.2007.05.057. Epub 2007 Aug 10.
2
Cardiovascular protection using beta-blockers: a critical review of the evidence.使用β受体阻滞剂进行心血管保护：对证据的批判性综述。
J Am Coll Cardiol. 2007 Aug 14;50(7):563-72. doi: 10.1016/j.jacc.2007.04.060. Epub 2007 Jul 30.
3
The vasodilatory beta-blockers.血管舒张性β受体阻滞剂
Curr Hypertens Rep. 2007 Aug;9(4):269-77. doi: 10.1007/s11906-007-0050-2.
4
Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: data from the Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) trial.奈必洛尔在老年心力衰竭患者中的耐受性及剂量相关效应：来自奈必洛尔干预对老年心力衰竭患者结局和再住院率影响的研究（SENIORS）试验的数据
Am Heart J. 2007 Jul;154(1):109-15. doi: 10.1016/j.ahj.2007.03.025.
5
Carvedilol prevents and reverses hypertrophy-induced cardiac dysfunction.卡维地洛可预防并逆转肥大诱导的心脏功能障碍。
Pharmacology. 2007;80(2-3):166-76. doi: 10.1159/000103384. Epub 2007 Jun 4.
6
Celiprolol, a selective beta1-blocker, reduces the infarct size through production of nitric oxide in a rabbit model of myocardial infarction.塞利洛尔，一种选择性β1受体阻滞剂，在兔心肌梗死模型中通过一氧化氮的产生减少梗死面积。
Circ J. 2007 Apr;71(4):574-9. doi: 10.1253/circj.71.574.
7
Antioxidant activity of carvedilol in cardiovascular disease.卡维地洛在心血管疾病中的抗氧化活性。
J Hypertens. 2007 Apr;25(4):731-41. doi: 10.1097/HJH.0b013e3280127948.
8
Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET.在心力衰竭中，卡维地洛比美托洛尔更能有效预防血管事件：COMET研究结果。
J Am Coll Cardiol. 2007 Mar 6;49(9):963-71. doi: 10.1016/j.jacc.2006.10.059. Epub 2007 Feb 20.
9
Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET).美托洛尔和卡维地洛对慢性心力衰竭患者既往存在的糖尿病及新发糖尿病的影响：来自卡维地洛或美托洛尔欧洲试验（COMET）的数据。
Heart. 2007 Aug;93(8):968-73. doi: 10.1136/hrt.2006.092379. Epub 2007 Jan 19.
10
How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis.β受体阻滞剂作为高血压一线治疗药物的证据有多充分？系统评价与荟萃分析。
J Hypertens. 2006 Nov;24(11):2131-41. doi: 10.1097/01.hjh.0000249685.58370.28.
Zotero 插件